NCT07052708 The Impact of Medication Adherence in Patients With Type 2 Diabetes and Disabilities Status COMPLETED Phase N/A
NCT07033585 Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT07032844 Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT) Status NOT_YET_RECRUITING Phase NA
NCT07032688 A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes Status RECRUITING Phase PHASE1
NCT07032311 Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk Status NOT_YET_RECRUITING Phase NA
NCT07030868 A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes Status TERMINATED Phase PHASE2
NCT07026968 A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT07023172 Multicenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin Tablets Status RECRUITING Phase N/A
NCT07011147 Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery Status RECRUITING Phase NA
NCT07005986 Role of Circulating Pyrophosphate as a Biomarker of Mediacalcinosis in Type 2 Diabetic Patients Status RECRUITING Phase NA
NCT07005362 Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D Status RECRUITING Phase N/A
NCT07003191 Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07002125 Whole Body Vibration Therapy in Individuals With Type 2 Diabetes Status RECRUITING Phase NA
NCT06993792 A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06993454 Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis Status RECRUITING Phase NA
NCT06989723 Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes Status RECRUITING Phase PHASE4